STAND UP TO CANCER® (SU2C) has awarded $6 million to a multi-institutional team headed by Mount Sinai researchers to collaborate with other New York institutions in an initiative that addresses disparities in cancer clinical trials participation by patients who are Black, indigenous, and people of color.
Nina Bickell, MD, MPH
The SU2C Health Equity Breakthrough Team will be led by Nina Bickell, MD, MPH, Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai and Co-lead of Cancer Prevention and Control for The Tisch Cancer Institute at Mount Sinai. The team includes doctors and scientists specializing in social science and clinical research from four New York institutions serving some of the most diverse and medically underserved communities in the United States.
